25 results on '"Florescu, Marie"'
Search Results
2. Reflex testing for RAS and BRAF mutations in metastatic colorectal cancer: A single Canadian academic oncology center experience.
3. Association between immune-related adverse events and microbiome composition in patients with advanced non–small cell lung cancer treated with immunotherapy.
4. The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and the influence of the NLR in NSCLC patients treated with immunotherapy.
5. High intensity interval training safety and efficacy in patients with advanced NSCLC receiving systemic treatment: Results of a prospective trial.
6. A phase II trial combining nivolumab and stereotactic brain radiosurgery for treatment of brain metastases in patients with NSCLC.
7. Angiotensin-converting enzyme inhibitor prescription is associated with decreased progression-free survival (PFS) and overall survival (OS) in patients with lung cancers treated with PD-1/PD-L1 immune checkpoint blockers.
8. Effect of body mass index and age on survival in patients with advanced lung cancer treated with anti-PD-1 immune checkpoint inhibitors.
9. Prognostic impact of paraneoplastic syndromes in patients with small cell lung cancer, real-world data.
10. Impact of different risk factors on survival of malignant pleural mesothelioma.
11. Tyrosine kinase inhibitor (TKI) cessation in advanced non-small-cell lung cancer (aNSCLC) for improved detection of EGFR-mutated (EGFRm) circulating tumor DNA (ctDNA).
12. Prognosis in young women under 40 with brain metastasis from breast cancer.
13. Prognosis of thoracic radiation-induced metastatic NSCLC.
14. Does blood sugar impact on metastatic non-small cell lung cancer (NSCLC) outcome?
15. Survival impact of aggressive treatment on patients with oligometastatic non-small cell lung cancer (NSCLC).
16. Adjuvant chemotherapy outcome in unselected single-center non-small cell lung cancer (NSCLC) population.
17. Phase I and II studies of the decitabine–genistein drug combination in advanced solid tumors.
18. IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial.
19. Use of positron emission tomography-computed tomography (PET-CT) scan in cancer patients: A single Canadian academic oncology center experience.
20. Survival impact of EGFR TKI on patients with lepidic brochioalveolar metastatic non-small cell lung cancer (NSCLC).
21. NSCLC driver mutations in the Quebec population: Epidemiologic and clinical evaluation.
22. Correlation between CD4 lymphocytes count and the opportunistic infections in treated glioblastoma.
23. Impact of local and systemic treatment on survival and on brain relapse of patients with localized or metastatic non-small cell lung cancer who develop brain metastasis.
24. Impact of asbestos exposure on survival and treatment of patients with malignant mesothelioma.
25. Economic Analysis of NCIC CTG JBR.10: A Randomized Trial of Adjuvant Vinorelbine Plus Cisplatin Compared With Observation in Early Stage Non–Small-Cell Lung Cancer—A Report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.